Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 1 | Journal of Cannabis Research

Fig. 1

From: C. elegans as a test system to study relevant compounds that contribute to the specific health-related effects of different cannabis varieties

Fig. 1

Kaplan-Meier survival rate of C. elegans exposed to different types of cannabis. C. elegans was exposed to 5, 50, and 100 μg/mL extracts obtained from the Δ9 -tetrahydrocannabinol (THC)-rich cannabis variety MGC 1101 (A–C) and the cannabidiol (CBD)-rich variety MGC 1013 (D–F). Vehicle control (Milli-Q water (MQ)/dimethyl sulfoxide (DMSO)) and different doses of A polar fraction (PF) of MGC 1101; B non-polar fraction (NPF) of MGC 1101; C decarboxylated non-polar fraction (NPFdec) of MGC 1101; D PF of MGC 1013; E NPF of MGC 1013; F NPFdec of MGC 1013. Kaplan-Meier survival analysis was used to compare the vehicle control (DMSO) condition to the experimental conditions. *=false discovery rate (FDR)-corrected p < .05; *** = FDR-corrected p < .001

Back to article page

Journal of Cannabis Research

ISSN: 2522-5782